These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15159300)

  • 21. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women.
    Shu XO; Jin F; Dai Q; Wen W; Potter JD; Kushi LH; Ruan Z; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):483-8. PubMed ID: 11352858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer.
    Zheng W; Xie DW; Jin F; Cheng JR; Dai Q; Wen WQ; Shu XO; Gao YT
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):147-50. PubMed ID: 10698474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM; Shu XO; Gao YT; Cai Q; Jin F; Zheng W
    Cancer; 2005 Jun; 103(11):2228-35. PubMed ID: 15856430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk.
    Ahn J; Gammon MD; Santella RM; Gaudet MM; Britton JA; Teitelbaum SL; Terry MB; Neugut AI; Josephy PD; Ambrosone CB
    Cancer Res; 2004 Oct; 64(20):7634-9. PubMed ID: 15492293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
    Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
    Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.
    Dai Q; Cai QY; Shu XO; Ewart-Toland A; Wen WQ; Balmain A; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2065-70. PubMed ID: 15598762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG; Chang JH; Gertig DM; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
    Breast Cancer Res; 2005; 7(3):R353-6. PubMed ID: 15987430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases.
    Kelsey KT; Hankinson SE; Colditz GA; Springer K; Garcia-Closas M; Spiegelman D; Manson JE; Garland M; Stampfer MJ; Willett WC; Speizer FE; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):511-5. PubMed ID: 9232338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrates and the risk of breast cancer among Mexican women.
    Romieu I; Lazcano-Ponce E; Sanchez-Zamorano LM; Willett W; Hernandez-Avila M
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1283-9. PubMed ID: 15298947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
    Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
    De Vivo I; Hankinson SE; Colditz GA; Hunter DJ
    Cancer Res; 2003 Sep; 63(17):5236-8. PubMed ID: 14500352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women.
    Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF
    Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.